moatshark My

All holdings

Icon

ICLR

Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them

Managers holding
5
In their latest 13F (Q3 2026)
See who
Value held
$1.8bn
Combined value at quarter end
Last quarter
4 bought
1 sold or trimmed
Fund portfolios
3
Funds holding it
See which
Price at Q2 ’26 end
$173.71
+57.0% in the quarter

Prices here are quarter-end prices implied by the 13F filings. Today’s price on Yahoo Finance

Share price change by quarter

-8.3%Q3 ’24
-27.0%Q4 ’24
-16.6%Q1 ’25
-16.9%Q2 ’25
+20.3%Q3 ’25
+4.1%Q4 ’25
-39.3%Q1 ’26
+57.0%Q2 ’26
Q3 ’24: -8.3%; Q4 ’24: -27.0%; Q1 ’25: -16.6%; Q2 ’25: -16.9%; Q3 ’25: +20.3%; Q4 ’25: +4.1%; Q1 ’26: -39.3%; Q2 ’26: +57.0%

Change in the quarter-end price implied by managers’ 13F filings, adjusted for stock splits. Excludes dividends.

Managers holding it, by quarter

2Q4 ’23
2Q1 ’24
2Q2 ’24
2Q3 ’24
4Q4 ’24
5Q1 ’25
7Q2 ’25
6Q3 ’25
5Q4 ’25
5Q1 ’26
5Q2 ’26
0Q3 ’26
Q4 ’23: 2; Q1 ’24: 2; Q2 ’24: 2; Q3 ’24: 2; Q4 ’24: 4; Q1 ’25: 5; Q2 ’25: 7; Q3 ’25: 6; Q4 ’25: 5; Q1 ’26: 5; Q2 ’26: 5; Q3 ’26: 0

Counts the managers on this site whose 13F for that quarter includes Icon.

Who holds it

Each manager’s latest 13F, sorted by how much of their portfolio it is. Changes are against their previous quarter.

Managers holding Icon
Brave Warrior Advisors11.9%$548m$548mAdded +5.2%2 qtrs
Ruane, Cunniff & Goldfarb (Sequoia)5.5%$356m$356mAdded +25%7 qtrs
Muhlenkamp & Company3.3%$11.5m$11.5mAdded +0.5%4 qtrs
First Pacific Advisors (FPA)1.3%$105m$105mTrimmed -39%16 qtrs
Harris Associates (Oakmark)1.0%$776m$776mAdded +2.7%5 qtrs

Download the holders: CSV · JSON · Markdown

Directors buying and selling

Open-market trades by directors, officers and 10% holders over the last 12 months. How this works
From their Form 4 filings with the SEC. Grants, option exercises and shares sold to pay tax are left out.
Insider purchases and sales of Icon
Bought or soldFiling
17 Sep 2026Murphy Ronan MartinDirector▼ Sold5,005$175.00$876kForm 4
17 Sep 2026Mccague Eugene PacelliDirector▼ Sold3,255$175.00$570kForm 4
16 Sep 2026Climax John DrDirector▼ Sold5,005$175.00$876kForm 4
11 Aug 2026Murray CiaranDirector▼ Sold1,880$164.47$309kForm 4
11 Aug 2026Clerkin Nigel Bernard JohnChief Financial Officer▼ Sold1,591$164.47$262kForm 4
11 Aug 2026O'Neill JulieDirector▼ Sold642$164.47$106kForm 4
11 Aug 2026Climax John DrDirector▼ Sold591$164.47$97kForm 4
11 Aug 2026Grais LindaDirector▼ Sold590$164.47$97kForm 4
11 Aug 2026Murray CiaranDirector▼ Sold305$163.77$50kForm 4
11 Aug 2026Murray CiaranDirector▼ Sold280$162.72$46kForm 4
11 Aug 2026Clerkin Nigel Bernard JohnChief Financial Officer▼ Sold259$163.77$42kForm 4
11 Aug 2026Clerkin Nigel Bernard JohnChief Financial Officer▼ Sold237$162.72$39kForm 4
11 Aug 2026Murray CiaranDirector▼ Sold212$165.51$35kForm 4
11 Aug 2026Clerkin Nigel Bernard JohnChief Financial Officer▼ Sold180$165.51$30kForm 4
11 Aug 2026O'Neill JulieDirector▼ Sold105$163.77$17kForm 4
11 Aug 2026Grais LindaDirector▼ Sold97$163.77$16kForm 4
11 Aug 2026Mccague Eugene PacelliDirector▼ Sold96$163.77$16kForm 4
11 Aug 2026Climax John DrDirector▼ Sold95$163.77$16kForm 4
11 Aug 2026O'Neill JulieDirector▼ Sold95$162.72$15kForm 4
11 Aug 2026Climax John DrDirector▼ Sold88$162.72$14kForm 4

About the company

Sector
Health care · Services-Commercial Physical & Biological Research
Shares outstanding
77m at 31 Dec 2025
SEC filings
Annual reports and other filings on EDGAR

Revenue and profit

$1.3bn2013
$1.6bn2015
$1.8bn2017
$2.8bn2019
$5.5bn2021
$8.1bn2023
$8.3bn2025
2013: $1.3bn; 2014: $1.5bn; 2015: $1.6bn; 2016: $1.7bn; 2017: $1.8bn; 2018: $2.6bn; 2019: $2.8bn; 2020: $2.8bn; 2021: $5.5bn; 2022: $7.7bn; 2023: $8.1bn; 2024: $8.2bn; 2025: $8.3bn
Icon revenue and net income by year
YearRevenueNet income
2025$8.3bn$229m
2024$8.2bn$739m
2023$8.1bn$554m
2022$7.7bn$505m
2021$5.5bn$153m
2020$2.8bn$332m
2019$2.8bn$374m
2018$2.6bn$323m
2017$1.8bn$281m
2016$1.7bn$262m
2015$1.6bn$240m
2014$1.5bn$172m
2013$1.3bn$103m

From the company’s XBRL financial statements filed with the SEC, for each financial year. Gaps mean the company didn’t report that figure in a standard form.

In fund portfolios

US-registered funds run by these managers that hold Icon, from their latest N-PORT filings.

Funds holding Icon
Sequoia FundRuane, Cunniff & Goldfarb (Sequoia)4.2%$152m30 Jun 2026
Muhlenkamp FundMuhlenkamp & Company2.9%$7.6m30 Jun 2026
FPA Crescent FundFirst Pacific Advisors (FPA)0.5%$66.4m30 Jun 2026